Utilisation of co-testing (human papillomavirus DNA testing and cervical cytology) after treatment of CIN: a survey of GPs’ awareness and knowledge

Utilisation of co-testing (human papillomavirus DNA testing and cervical cytology) after treatment of CIN: a survey of GPs’ awareness and knowledge

Background - Patients have an increased risk of persistent/recurrent cervical disease if they received treatment for a high-grade squamous intraepithelial lesion (HSIL). Consequently, understanding whether co-testing (human papillomavirus [HPV] DNA testing and cervical cytology) is fully utilised by...

Full description

Bibliographic Details
Main Authors: Munro, A., Codde, J., Semmens, James, Leung, Y., Spilsbury, Katrina, Williams, Vincent, Steel, N., Cohen, P., Pavicic, H., Westoby, V., O'Leary, Peter
Format: Journal Article
Published: The Royal Australian College of General Practitioners 2015
Subjects:
human papillomavirus [HPV] DNA
cytology
cervical disease
high-grade squamous intraepithelial lesion (HSIL)
Online Access:http://www.racgp.org.au/download/Documents/AFP/2015/January/February/research-munro.pdf
http://hdl.handle.net/20.500.11937/10779

Internet

http://www.racgp.org.au/download/Documents/AFP/2015/January/February/research-munro.pdf
http://hdl.handle.net/20.500.11937/10779

Similar Items